Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VINC | US
-0.02
-5.15%
Healthcare
Biotechnology
01/01/1970
17/10/2024
0.38
0.39
0.41
0.37
Vincerx Pharma Inc. a clinical-stage biopharmaceutical company researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236 a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma Inc. was founded in 2019 is based in Palo Alto California.
View LessNegative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
215.9%1 month
153.7%3 months
107.6%6 months
103.8%-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.40
Range1M
0.42
Range3M
0.49
Rel. volume
0.33
Price X volume
124.63K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc | VNDA | Biotechnology | 4.735 | 0 | -3.37% | n/a | |
Viking Therapeutics Inc | VKTX | Biotechnology | 64.615 | 0 | -1.88% | n/a | |
VIRACTA THERAPEUTICS INC | VIRX | Biotechnology | 0.2228 | 0 | -0.45% | n/a | |
Vigil Neuroscience Inc. Common Stock | VIGL | Biotechnology | 3.99 | 0 | 3.37% | n/a | |
Verve Therapeutics Inc. Common Stock | VERV | Biotechnology | 5.46 | 0 | -2.50% | n/a | |
Vera Therapeutics Inc. Class A Common Stock | VERA | Biotechnology | 39.89 | 0 | -0.25% | n/a | |
Veracyte Inc | VCYT | Biotechnology | 34.31 | 0 | -1.18% | n/a | |
Vaccinex Inc - Ordinary Shares | VCNX | Biotechnology | 2.52 | 0 | -3.08% | n/a | |
Vericel Corporation | VCEL | Biotechnology | 40.67 | 0 | -1.45% | n/a | |
Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0.002 | 0 | 0.00% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a | |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 0.53 | - |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | - | 15.30 | - |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 107.63 | 72.92 | Riskier |
Debt to Equity | - | -1.24 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | - | 3.78B | - |